HIFU Resource Center Online at www.urotoday.comEDAP and the Ablatherm-HIFU now have a HIFU section in the most popular urology web site in the world : http://www.urotoday.com . Urotoday.com is a scientific web site serving urologists visited by more than 50,000 urologists every month worldwide.

Ablatherm-HIFU information is visible in the "Prostate Cancer" section. On the main page of this section is a button link in the middle called "HIFU Resource Center," or a link on the left side with the same name.

Information is also visible in the "Treatment for Localized" section accessible through the link on the left side, alongside material on radiation, brachytherapy, cryotherapy and watchful waiting.

In the HIFU resource center, are listed (The topic headings in bold link to each section):

·        Clinical References: A thorough documentation of a publications, abstracts and conference materials presented regarding Ablatherm-HIFU treatment of localized prostate cancer, many of them linked to source documents or summaries

·        Clinical Resources: A description of HIFU, the Ablatherm, Clinical Information and a summary of Clinical Results including large population outcomes and long-term follow-up

·        Current Clinical Trials: Including summaries of fully enrolled multi-center trials in Europe and France as well as the currently enrolling US clinical trials

·        Media Resources: offering an animated description of Ablatherm-HIFU treatment as well as webcasts of recent EAU presentations given at the 2006 HIFU Symposiums discussing the physical principles of HIFU (Gail ter Haar), salvage therapy outcomes after radiation failure (F-J Murat), efficacy and safety outcomes from 10 years (Stefan Thuroff) and a discussion of HIFU's role in treating patients through minimally invasive therapy (U. Tirelli).

With this new resource thousands of urologists are able to find information on Ablatherm and HIFU therapy as well as see the popular HIFU symposium presentations made at the 2006 EAU Congress. Visitors to www.urotoday.com come from the USA (50%), Europe (25%) and around the globe.